A Phase III Multi-center, Randomized, Double-blind, Active-controlled Study to Evaluate the Efficacy and Safety of Ilaprazole (20mg QD) in Adult Patients With Erosive Esophagitis.
Phase of Trial: Phase III
Latest Information Update: 14 Jan 2012
At a glance
- Drugs Ilaprazole; Lansoprazole
- Indications Erosive oesophagitis
- Focus Therapeutic Use
- 14 Jan 2012 New trial record